Weight-loss doctor warns against unproven GLP-1 microdosing trend

The Story

In an opinion article published by STAT News on May 29, 2026, Dr. Jody Dushay, an assistant professor at Harvard Medical School, warns that “microdosing” GLP-1 medications for cosmetic weight loss lacks scientific evidence and carries unknown risks. Dushay states that there is no single definition of microdosing for weight loss and no legitimate long-term data to support the practice.

Key Facts

• Dr. Jody Dushay says microdosing GLP-1s is “not a thing” and there are no legitimate long-term data to support it.
• The term has been popularized by direct-to-consumer companies selling compounded products that are not FDA-approved GLP-1 therapies.
• None of the compounded products have been studied for short- or long-term safety, efficacy, or weight regain after stopping.
• There is no way to convert dosing of a compounded product to a real GLP-1 because they are sold in different units.
• Some clinics advertise microdosing Zepbound by drawing up less than the full amount in a single-use vial, but this has not been studied and risks contaminating the vial if used more than once.
• FDA-approved doses should only be increased under medical supervision.
• The article notes that research on smaller doses of real GLP-1 therapies for other conditions is ongoing.

Conflicting Reports

No conflicting reports identified in the source article.

Still Unclear

• What exactly is in the compounded products used for microdosing.
• The long-term effects of microdosing GLP-1s.
• Whether smaller doses of real GLP-1 therapies will be effective or safe for conditions like dementia or rheumatoid arthritis.

Misconceptions

• The article addresses the misconception that microdosing GLP-1s is a safe, proven method for cosmetic weight loss or other conditions.
• The article clarifies that individualizing dosing under medical supervision (e.g., adjusting doses for side effects or maintenance) is not the same as microdosing.

Key Figures

• Dr. Jody Dushay, M.D., assistant professor of medicine at Harvard Medical School and attending endocrinologist at Beth Israel Deaconess Medical Center.

Sources: statnews.com